Skip to main content
Funded Studies

Philippe Huot, MD, PhD

Assistant Professor and Movement Disorder Neurologist at McGill University, Montreal Neurological Institute

Location: Montreal PQ Canada

Dr. Huot's lab aims to discover novel pharmacological therapeutics to treat motor and non-motor complications of chronic treatment with levodopa in Parkinson's disease, as well as to find therapies that will slow and, hopefully, reverse Parkinson's disease progression. Dr Huot's lab uses state-of-the-art experimental models of Parkinson's disease to assess the effectiveness of novel drugs. His team employs cutting-edge molecular biology techniques to determine the mechanisms and brain areas underlying the effects drugs acting at new therapeutic targets. To maximize the translational potential of the molecules tested, Dr Huot's team conducts, with a network of collaborators, in vivo brain receptor occupancy and pharmacokinetic studies.


Associated Grants

  • Bitopertin to Alleviate Dyskinesia in Parkinson's Disease

    2018


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.